Crossmark Global Holdings’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$946K Buy
33,058
+1,143
+4% +$36.3K 0.01% 641
2026
Q1
$1M Sell
31,915
-2,057
-6% -$64.8K 0.01% 603
2025
Q4
$1M Buy
33,972
+67
+0.2% +$1.86K 0.01% 604
2025
Q3
$856K Buy
33,905
+1,286
+4% +$31.3K 0.01% 682
2025
Q2
$783K Buy
32,619
+19,178
+143% +$445K 0.01% 701
2025
Q1
$308K Buy
13,441
+31
+0.2% +$748 0.01% 1075
2024
Q4
$340K Buy
13,410
+19
+0.1% +$481 0.01% 997
2024
Q3
$334K Buy
+13,391
New +$397K 0.01% 1036

Other funds holding RTO

Crossmark Global Holdings's RTO Position: Q2 2026 in Review

Crossmark Global Holdings increased its Rentokil (RTO) stake by 3.6% in Q2 2026, buying an estimated $36.3K and bringing the position to 33,058 shares worth $946K. The position accounts for 0.01% of the portfolio, ranked #641.

Crossmark Global Holdings first reported a position in RTO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1M in Q1 2026. 23 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Crossmark Global Holdings held 33,058 shares of Rentokil worth $946K as of Q2 2026.
  • Crossmark Global Holdings bought 1,143 Rentokil shares in Q2 2026, an estimated $36.3K.
  • Rentokil made up 0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #641 holding.
  • Crossmark Global Holdings first reported a position in Rentokil in Q3 2024 and has held it in 8 quarters since.
  • Crossmark Global Holdings's Rentokil position peaked at $1M in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.